NCT06259643

Brief Summary

This study is a prospective interventional study. It will be conducted at a single center with participants who have neuromotor impairments. The primary objective is to assess and measure the clinical and psychosocial effects of a season of power wheelchair soccer among its participants presenting with severe motor impairments due to neuromuscular lesion. A maximum of twenty participants will be recruited and included in the same group. Data collection will be performed before, during, and after the wheelchair soccer season. The study will span the entire season, starting in November 2023 and ending in June 2024. Clinical and psychosocial assessments will be conducted every 3 months. Each assessment session will last 2 hours per participant. Before and after the wheelchair soccer season matches, we will evaluate parameters related to the physical load of the sport. These evaluations will last 10 minutes per participant.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 23, 2024

Completed
22 days until next milestone

First Posted

Study publicly available on registry

February 14, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2024

Completed
Last Updated

February 14, 2024

Status Verified

February 1, 2024

Enrollment Period

8 months

First QC Date

January 23, 2024

Last Update Submit

February 6, 2024

Conditions

Outcome Measures

Primary Outcomes (13)

  • Balance

    Balance will be measured using the Trunk control measurement scale. Scores range from 0 to 58, where a higher score displays better trunk control.

    Throughout the entire study (an average of 8 months)

  • Balance

    Balance will be measured using the Level of sitting scale. Levels range from 1 to 8, where a higher score demonstrates better sitting balance.

    Throughout the entire study (an average of 8 months)

  • Balance

    Balance will be measured using the function section of the Seated Postural Control measure. Scores range from 12 to 48, where a higher score is attributed to individuals with better postural control.

    Throughout the entire study (an average of 8 months)

  • Sensorimotor impairment

    Sensorimotor impairment will be measured by the Fugl-Meyer assessment.

    Throughout the entire study (an average of 8 months)

  • Hyperactivity of the muscles

    Hyperactivity of the muscles will be measured using the Australian Spasticity Assessment scale of the upper-limb main muscle groups. Scores per muscle groups range from 0 to 4, where a higher score represents greater spasticity and more hyperactivity in the muscle group.

    Throughout the entire study (an average of 8 months)

  • Hyperactivity of the muscles

    Hyperactivity of the muscles will be measured using the Penn Spasm Frequency Scale. Scores range from 0 to 4, where a higher score represents more frequent spasms and hyperactivity of the muscles.

    Throughout the entire study (an average of 8 months)

  • Pain

    Pain perceived by the participants in their daily life will be measured using the PROMIS pain-pediatric Short Form V2 questionnaire. Scores range from 8 to 40, where a higher score displays more pain in everyday life.

    Throughout the entire study (an average of 8 months)

  • Quality of life

    Quality of life will be assessed using the KIDSCREEN 27 questionnaire. Scores range from 10 and 50, where 50 represents a very high health-related quality of life.

    Throughout the entire study (an average of 8 months)

  • Skills to manage and move power wheelchair

    Skills to manage and move power wheelchair will be assessed by the Wheelchair Skills Test Questionnaire version 4.2. Scores range from 0 to 100%, where a greater percentage represents better skills.

    Throughout the entire study (an average of 8 months)

  • Social participation

    Social participation will be assessed using the Questionnaire of young people's participation.Scores range from 0 to 239, where a higher score displays greater social participation.

    Throughout the entire study (an average of 8 months)

  • Autonomy during activities of daily life

    Autonomy during activities of daily life will be assessed using the Impact on participation and autonomy questionnaire. A participation score (range: 30-155) and a problem score (0-16) are produced by summing items in each scale. For both, a higher score represent poorer autonomy and more severe difficulty.

    Throughout the entire study (an average of 8 months)

  • Strength of the upper-limbs

    Strength of the main muscle groups of the upper-limb will be measured using a Microfet 2 dynamometer.

    Throughout the entire study (an average of 8 months)

  • Passive range of motion the upper-limbs

    Passive range of motion of the upper-limbs will be measured using a goniometer.

    Throughout the entire study (an average of 8 months)

Secondary Outcomes (4)

  • Body temperature

    Throughout the entire study (an average of 8 months)

  • Blood oxygen saturation

    Throughout the entire study (an average of 8 months)

  • Heart beat rate

    Throughout the entire study (an average of 8 months)

  • Blood pressure

    Throughout the entire study (an average of 8 months)

Other Outcomes (2)

  • Satisfaction with the power wheelchair soccer practices

    Throughout the entire study (an average of 8 months)

  • Demographic variables

    Throughout the entire study (an average of 8 months)

Study Arms (1)

Power wheelchair soccer

EXPERIMENTAL

soccer game performed with a wheelchair

Other: Power wheelchair soccer

Interventions

Participants will practice power wheelchair soccer during the course of the power wheelchair soccer season (starting in November 2023 and ending in June 2024). Sessions are given once a week, by a coach with experience in this adaptive sport.

Power wheelchair soccer

Eligibility Criteria

Age12 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Being a male or female between the ages of 12 and 50.
  • Presenting with severe motor impairments due to neuromotor and/or musculoskeletal impairment.
  • Using a power wheelchair in everyday life.
  • Being part of a power wheelchair soccer team.
  • Committing to participating in the 2023-2024 season of their sport within the team.

You may not qualify if:

  • Practicing another adaptive sport outside of power wheelchair soccer in a regular way (once a week or more).
  • Occasionally practicing power wheelchair soccer (twice a month or less).
  • Presenting with severe cognitive impairments affecting understanding of instructions on how to answer questionnaires and undertake tests.
  • Presenting with contraindications towards the practice of an adaptive sport such as power wheelchair soccer.
  • Participating in another study at baseline.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neuromusculoskeletal Lab

Brussels, 1200, Belgium

RECRUITING

MeSH Terms

Conditions

Neuromuscular DiseasesCerebral Palsy

Condition Hierarchy (Ancestors)

Nervous System DiseasesBrain Damage, ChronicBrain DiseasesCentral Nervous System Diseases

Central Study Contacts

Louise Declerck, PT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 23, 2024

First Posted

February 14, 2024

Study Start

November 1, 2023

Primary Completion

June 15, 2024

Study Completion

June 15, 2024

Last Updated

February 14, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations